The fund will primarily invest in medical device, diagnostic, and digital health companies.
Cross-Border Impact Ventures (CBIV), a Canada-based venture capital firm, has raised $30m in the initial close of its Women’s and Children’s Health Technology Fund.
The fund will primarily invest in medical device, diagnostic, and digital health companies based in North America, Europe, and Israel. Its secondary focus is on commercial stage companies in emerging markets with global technology transfer potential.
CBIV is targeting more than $100m for the fund, which has an undisclosed strategic healthcare as a limited partner (LP).
Its disclosed…
